UBS Group AG (UBS) P/E Ratio History
ExpensiveTrading at 27.2x vs 5Y avg 13.0x · 95th percentile · Material premium to history · Data 2000–2025
Loading P/E history...
P/E Ratio Analysis
As of June 20, 2026, UBS Group AG (UBS) trades at a price-to-earnings ratio of 27.2x, with a stock price of $50.80 and trailing twelve-month earnings per share of $1.90.
The current P/E is 108% above its 5-year average of 13.0x. Over the past five years, UBS's P/E has ranged from a low of 2.1x to a high of 52.2x, placing the current valuation at the 95th percentile of its historical range.
Compared to the Financial Services sector median P/E of 13.6x, UBS trades at a 100% premium to its sector peers. The sector includes 783 companies with P/E ratios ranging from 0.0x to 196.5x.
The PEG ratio of 24.58 (P/E divided by 23% EPS growth) suggests the stock may be expensive relative to its earnings growth. Peter Lynch popularized the rule that a PEG below 1.0 indicates an attractive entry point.
Relative to the broader market, UBS trades roughly in line with the S&P 500 median P/E of 24.4x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our UBS DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
UBS Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
UBS P/E vs Peers
Wealth and private banking focused banks peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $356B | 21.9 | 2.29 | +28% | |
| $348B | 21.4 | 1.36 | +27% | |
| $424B | 14.7 | 0.96 | +19% | |
| $267B | 20.5 | 2.52 | +17% | |
| $909B | 16.2 | 0.92 | +2% | |
| $265B | 13.0Lowest | 0.18Best | +18% | |
| $100B | 19.2 | 1.36 | +28% | |
| $49B | 17.9 | 2.17 | +14% | |
| $31B | 15.1 | 0.70 | +6% | |
| $161B | 19.7 | 1.15 | +56%Best |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
UBS Historical P/E Data (2000–2025)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2025 Q4 | Dec 31 2025 | $46.31 | $2.27 | 20.4x | +11% |
| FY2025 Q3 | Sep 29 2025 | $41.33 | $2.21 | 18.7x | +2% |
| FY2025 Q2 | Jun 30 2025 | $33.82 | $1.90 | 17.8x | -3% |
| FY2025 Q1 | Mar 31 2025 | $30.63 | $1.52 | 20.2x | +10% |
| FY2024 Q4 | - | $30.32 | $1.53 | 19.8x | +8% |
| FY2024 Q3 | Sep 30 2024 | $30.91 | $1.23 | 25.2x | +37% |
| FY2024 Q2 | Jun 30 2024 | $29.54 | $0.57 | 52.2x | +185% |
| FY2024 Q1 | Mar 31 2024 | $30.72 | $8.74 | 3.5x | -81% |
| FY2023 Q4 | Dec 31 2023 | $30.90 | $8.54 | 3.6x | -80% |
| FY2023 Q3 | Sep 30 2023 | $24.65 | $9.11 | 2.7x | -85% |
| FY2023 Q2 | Jun 30 2023 | $20.27 | $9.85 | 2.1x | -89% |
| FY2023 Q1 | Mar 31 2023 | $21.34 | $1.95 | 10.9x | -40% |
| FY2022 Q4 | Dec 31 2022 | $18.67 | $2.24 | 8.3x | -55% |
| FY2022 Q3 | Sep 30 2022 | $14.51 | $2.12 | 6.8x | -63% |
| FY2022 Q2 | - | $16.22 | $2.23 | 7.3x | -60% |
| FY2022 Q1 | - | $19.54 | $2.17 | 9.0x | -51% |
| FY2021 Q4 | Dec 31 2021 | $17.87 | $2.05 | 8.7x | -52% |
| FY2021 Q3 | - | $15.94 | $2.11 | 7.6x | -59% |
| FY2021 Q2 | Jun 30 2021 | $15.34 | $2.04 | 7.5x | -59% |
| FY2021 Q1 | Mar 31 2021 | $15.53 | $1.82 | 8.5x | -53% |
| FY2020 Q4 | - | $14.13 | $1.76 | 8.0x | -56% |
| FY2020 Q3 | Sep 30 2020 | $11.15 | $1.51 | 7.4x | -60% |
| FY2020 Q2 | - | $11.54 | $1.23 | 9.4x | -49% |
| FY2020 Q1 | - | $9.26 | $1.27 | 7.3x | -60% |
| FY2019 Q4 | - | $12.58 | $1.14 | 11.0x | -40% |
| FY2019 Q3 | Sep 30 2019 | $11.31 | $1.13 | 10.0x | -45% |
| FY2019 Q2 | Jun 30 2019 | $11.85 | $1.18 | 10.0x | -45% |
| FY2019 Q1 | Mar 31 2019 | $12.11 | $1.17 | 10.4x | -44% |
| FY2018 Q4 | Dec 31 2018 | $12.38 | $1.28 | 9.7x | -47% |
| FY2018 Q3 | Sep 30 2018 | $15.73 | $0.49 | 32.1x | +75% |
| FY2018 Q2 | Jun 30 2018 | $15.34 | $0.42 | 36.5x | +99% |
| FY2018 Q1 | Mar 31 2018 | $17.66 | $0.38 | 46.5x | +153% |
| FY2017 Q4 | Dec 31 2017 | $18.39 | $0.30 | 61.3x | +234% |
| FY2017 Q3 | Sep 30 2017 | $17.15 | $1.08 | 15.9x | -13% |
| FY2017 Q2 | Jun 30 2017 | $16.98 | $1.05 | 16.2x | -12% |
| FY2017 Q1 | Mar 31 2017 | $15.95 | $1.01 | 15.8x | -14% |
| FY2016 Q4 | Dec 31 2016 | $15.67 | $0.87 | 18.0x | -2% |
| FY2016 Q3 | Sep 30 2016 | $13.62 | $0.95 | 14.3x | -22% |
| FY2016 Q2 | - | $12.96 | $1.28 | 10.1x | -45% |
| FY2016 Q1 | - | $16.02 | $1.35 | 11.9x | -35% |
| FY2015 Q4 | - | $19.37 | $1.71 | 11.3x | -38% |
| FY2015 Q3 | Sep 30 2015 | $18.52 | $1.69 | 11.0x | -40% |
| FY2015 Q2 | - | $21.20 | $1.34 | 15.8x | -14% |
| FY2015 Q1 | - | $18.77 | $1.23 | 15.3x | -17% |
| FY2014 Q4 | Dec 31 2014 | $17.05 | $0.98 | 17.4x | -5% |
| FY2014 Q3 | - | $17.37 | $1.02 | 17.0x | -7% |
| FY2014 Q2 | Jun 30 2014 | $18.32 | $0.98 | 18.7x | +2% |
| FY2014 Q1 | Mar 31 2014 | $20.72 | $0.93 | 22.3x | +21% |
| FY2013 Q4 | - | $19.25 | $0.90 | 21.4x | +17% |
| FY2013 Q3 | Sep 30 2013 | $20.52 | $0.08 | 256.5x | +1298% |
| FY2012 Q2 | Jun 30 2012 | $11.71 | $0.86 | 13.6x | -26% |
| FY2012 Q1 | Mar 31 2012 | $14.02 | $1.02 | 13.7x | -25% |
| FY2011 Q4 | Dec 31 2011 | $11.83 | $1.23 | 9.6x | -48% |
| FY2011 Q3 | Sep 30 2011 | $11.43 | $1.47 | 7.8x | -58% |
| FY2011 Q2 | - | $18.26 | $1.61 | 11.3x | -38% |
| FY2011 Q1 | - | $18.05 | $1.78 | 10.1x | -45% |
| FY2010 Q4 | Dec 31 2010 | $16.47 | $1.81 | 9.1x | -50% |
| FY2010 Q3 | - | $17.03 | $1.76 | 9.7x | -47% |
| FY2010 Q2 | Jun 30 2010 | $13.22 | $1.18 | 11.2x | -39% |
| FY2010 Q1 | Mar 31 2010 | $16.28 | $0.34 | 47.9x | +161% |
| FY2007 Q3 | Sep 30 2007 | $53.25 | $4.62 | 11.5x | -37% |
| FY2007 Q2 | Jun 30 2007 | $60.01 | $5.71 | 10.5x | -43% |
| FY2007 Q1 | Mar 31 2007 | $59.43 | $4.69 | 12.7x | -31% |
| FY2006 Q4 | Dec 31 2006 | $60.33 | $4.67 | 12.9x | -30% |
| FY2006 Q3 | Sep 30 2006 | $59.31 | $5.53 | 10.7x | -42% |
| FY2006 Q2 | Jun 30 2006 | $54.85 | $5.69 | 9.6x | -47% |
| FY2006 Q1 | Mar 31 2006 | $54.99 | $5.26 | 10.5x | -43% |
| FY2005 Q4 | Dec 31 2005 | $47.58 | $5.00 | 9.5x | -48% |
| FY2005 Q3 | Sep 30 2005 | $42.75 | $3.72 | 11.5x | -37% |
| FY2005 Q2 | - | $38.92 | $3.34 | 11.7x | -36% |
| FY2005 Q1 | - | $42.20 | $3.29 | 12.8x | -30% |
| FY2004 Q4 | Dec 31 2004 | $41.92 | $3.12 | 13.4x | -27% |
| FY2004 Q3 | - | $35.17 | $2.85 | 12.3x | -33% |
| FY2004 Q2 | Jun 30 2004 | $35.53 | $2.79 | 12.7x | -31% |
| FY2004 Q1 | Mar 31 2004 | $37.24 | $2.59 | 14.4x | -22% |
| FY2003 Q4 | Dec 31 2003 | $33.99 | $2.13 | 16.0x | -13% |
| FY2003 Q3 | - | $28.12 | $1.43 | 19.7x | +7% |
| FY2003 Q2 | Jun 30 2003 | $27.70 | $1.14 | 24.3x | +33% |
| FY2003 Q1 | Mar 31 2003 | $21.35 | $1.19 | 18.0x | -2% |
| FY2002 Q4 | - | $24.06 | $1.14 | 21.1x | +15% |
| FY2002 Q3 | Sep 30 2002 | $20.50 | $1.33 | 15.4x | -16% |
| FY2002 Q2 | Jun 30 2002 | $24.95 | $1.30 | 19.2x | +5% |
| FY2002 Q1 | Mar 31 2002 | $24.88 | $0.81 | 30.7x | +67% |
| FY2001 Q4 | Dec 31 2001 | $25.00 | $0.80 | 31.2x | +70% |
| FY2001 Q3 | Sep 30 2001 | $23.08 | $1.02 | 22.6x | +23% |
| FY2001 Q2 | Jun 30 2001 | $23.67 | $1.28 | 18.5x | +1% |
| FY2001 Q1 | Mar 31 2001 | $24.00 | $1.72 | 14.0x | -24% |
| FY2000 Q4 | Dec 31 2000 | $27.23 | $1.95 | 14.0x | -24% |
Average P/E for displayed period: 18.4x
Full Stock Analysis
Deep dive into UBS consensus models and risk factors.
Should I Buy UBS?
Wall Street verdict, signals, and target summaries.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
26+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
UBS — Frequently Asked Questions
Quick answers to the most common questions about buying UBS stock.
What is UBS's P/E ratio?
UBS Group AG (UBS) trailing twelve-month P/E ratio is 27.2x, based on TTM diluted EPS of $1.90. The 5-year average P/E is 13.0x and the historical range spans 2.1x to 52.2x.
Is UBS stock overvalued or undervalued?
UBS trades at 27.2x P/E, above its 5-year average of 13.0x. The 95th percentile ranking within the 2.1x–52.2x historical range indicates a premium to historical valuation.
Is UBS stock expensive?
Yes, UBS is expensive relative to its own history. The current P/E of 27.2x is above the 5-year average of 13.0x and also above the Financial Services sector median of 13.6x. The stock sits at the 95th percentile of its 5-year valuation range.
What is UBS's historical P/E range?
Over the past 5 years, UBS's P/E ratio has ranged from 2.1x to 52.2x, with a median of 8.7x and an average of 13.0x. The current P/E of 27.2x places the stock at the 95th percentile of this range. Full historical data spans 2000–2025.
How does UBS's P/E compare to the S&P 500?
UBS trades at 27.2x P/E versus the S&P 500 median of 24.4x. The 11% premium to the market typically reflects higher expected earnings growth or quality.
How does UBS's valuation compare to Financial Services peers?
UBS Group AG P/E of 27.2x compares to the Financial Services sector median of 13.6x. The premium reflects expected growth above peers or stronger fundamentals. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is UBS's PEG ratio?
UBS PEG ratio is 24.58, based on a P/E of 27.2x and EPS growth of 23.0%. A PEG above 2.0 indicates a premium valuation relative to earnings growth — typically considered expensive.
What is UBS's earnings yield?
UBS earnings yield is 3.68%, the inverse of its 27.2x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.